Health
Researchers tie cold viruses used to deliver COVID-19 vaccine to rare blood clot risk – ABS-CBN News
German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among…
German researchers on Wednesday said that based on laboratory research, they believed they have found the cause of the rare but serious blood clotting events among some people who received COVID-19 vaccines made by AstraZeneca Plc and Johnson & Johnson.
The researchers, in a study not yet reviewed by experts, said COVID-19 vaccines that employ adenovirus vectors – cold viruses used to deliver vaccine material – send some of their payload into the nucleus of cells, where some of the instructions…
-
Noosa News18 hours agoProtest calls for shark net removal
-
General17 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News20 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General9 hours agoTeam Australia wins back-to-back Motocross of Nations titles